ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
177.42
1.43
(0.81%)
Closed July 04 3:00PM
177.42
0.00
(0.00%)
After Hours: 4:04PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
177.42
Bid
-
Ask
-
Volume
130,530
175.10 Day's Range 178.21
170.59 52 Week Range 344.04
Market Cap
Previous Close
175.99
Open
176.32
Last Trade
17663
@
177.42
Last Trade Time
Financial Volume
US$ 23,119,633
VWAP
177.1212
Average Volume (3m)
336,582
Shares Outstanding
38,764,917
Dividend Yield
-
PE Ratio
75.62
Earnings Per Share (EPS)
2.35
Revenue
1.06B
Net Profit
90.95M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Dover, Delaware, USA
Founded
1970
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was US$175.99. Over the last year, Penumbra shares have traded in a share price range of US$ 170.59 to US$ 344.04.

Penumbra currently has 38,764,917 shares outstanding. The market capitalization of Penumbra is US$6.88 billion. Penumbra has a price to earnings ratio (PE ratio) of 75.62.

PEN Latest News

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif., July 2, 2024 ALAMEDA, Calif., July 2, 2024 /PRNewswire/...

Penumbra, Inc. to Present at the Truist Securities MedTech Conference

Penumbra, Inc. to Present at the Truist Securities MedTech Conference PR Newswire ALAMEDA, Calif., June 4, 2024 ALAMEDA, Calif., June 4, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today...

Penumbra, Inc. to Present at the William Blair Growth Stock Conference

Penumbra, Inc. to Present at the William Blair Growth Stock Conference PR Newswire ALAMEDA, Calif., May 23, 2024 ALAMEDA, Calif., May 23, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
15.653.28928217966171.77181.2899171.1363954177.51445644CS
4-14.04-7.33312441241191.46198.61170.59387237182.81635912CS
12-42.15-19.196611559219.57224.3170.59336582195.45346711CS
26-63.4-26.3267170501240.82277.34170.59346257220.36446506CS
52-164.03-48.0392443989341.45344.04170.59373119234.18117566CS
156-97.87-35.5516001308275.29348.67114.865314551225.85608208CS
26013.047.93283854484164.38348.67107.5357777212.41802625CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DYADynaCERT Inc
$ 0.26
(30.00%)
588.14k
IVQInvesque Inc
$ 0.185
(23.33%)
500
GFRGreenfire Resources Ltd
$ 10.95
(15.26%)
14.53k
PYRPyroGenesis Canada Inc
$ 0.86
(14.67%)
323.54k
ITHInternational Tower Hill Mines Ltd New
$ 0.74
(13.85%)
21k
SFDNXT Energy Solutions Inc
$ 0.23
(-25.81%)
13k
WRXWestern Resources Corp
$ 0.07
(-17.65%)
83k
CNTCentury Global Commodities Corporation
$ 0.025
(-16.67%)
1,000
GMTNGold Mountain Mining Corp
$ 0.035
(-12.50%)
56.06k
LPENLoop Energy Inc
$ 0.035
(-12.50%)
31.65k
TRPTC Energy Corporation
$ 52.17
(0.02%)
4.71M
TDToronto Dominion Bank
$ 75.87
(-0.22%)
4.61M
POWPower Corp of Canada
$ 39.13
(0.57%)
4.18M
CNQCanadian Natural Resources Ltd
$ 49.82
(0.00%)
3.93M
VGCXVictoria Gold Corp
$ 0.95
(9.20%)
3.17M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 years ago
IPO should be out soon.
no symbol yet.
👍️0

Your Recent History

Delayed Upgrade Clock